ロード中...
Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study
AIM: To evaluate the safety and efficacy of sorafenib plus transarterial chemoembolization (TACE) treatment for intermediate hepatocellular carcinoma (HCC). METHODS: Sixty-seven patients with intermediate-stage [Barcelona Clinic liver cancer stage B (BCLC-B)] HCC who were treated with sorafenib plus...
保存先:
| 出版年: | World J Clin Cases |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Inc
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5955731/ https://ncbi.nlm.nih.gov/pubmed/29774219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v6.i5.74 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|